Page 43 - டஃப்ட்ஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer – Ms. Decker Brings 20 Years of Development Experience in the Life Sciences Industry – March 15, 2021 07:00 ET | Source: IGM Biosciences IGM Biosciences Mountain View, California, UNITED STATES MOUNTAIN VIEW, Calif., March 15, 2021 (GLOBE NEWSWIRE) IGM Biosciences, Inc. (IGM), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of Lisa L. Decker, Ph.D., to the newly created position of Chief Business Officer. Ms. Decker joins IGM with twenty years of experience in business development strategy, transactions and alliance management. Most recently, Ms. Decker was Chief Business Officer at Atreca, Inc., where she led business development, including the portfolio and alliance management functions.

United statesMountain viewLisal deckerDavid pittsFred schwarzerAtreca incNektar therapeuticsOffice of technology managementAlliance management business developmentUniversity of massachusetts medical schoolExchange commissionBiosciences incCollege of the holy crossTufts university school of medicineBusiness developmentChief business